Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Trevi Therapeutics, Inc.
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 28, 2026
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
May 27, 2026
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
May 27, 2026
Trevi Therapeutics to Participate in Upcoming May Events
May 26, 2026
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
May 25, 2026
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
May 25, 2026
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
May 25, 2026
Trevi Therapeutics to Participate in Upcoming Events
May 23, 2026
Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough
May 22, 2026
Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates
May 20, 2026
1
2
Next Page
→